Economic evaluation of single-inhaler triple therapy for chronic obstructive pulmonary disease in Thailand
Our study indicated that SITTs are not cost-effective at the current price compared with the current MITT for COPD treatment. However, FF/UMEC/VI could be a promising option, with an approximately 30% price reduction.
Authors
- Piyawat Dilokthornsakul (ORCID: https://orcid.org/0000-0002-7024-4217)
- Bunchai Chongmelaxme (ORCID: https://orcid.org/0000-0002-7750-6961)
- Anuchit Niyompattama
- Piyameth Dilokthornsakul
Institutions
- Chulalongkorn University (TH)
- Maharat Nakhon Ratchasima Hospital (TH)
- Nakornping Hospital (TH)
- Chiang Mai University (TH)
Publication Details
- Journal
- BMJ Open Respiratory Research
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1136/bmjresp-2025-003619
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00